# Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (Text with EEA relevance), Article 50: Suitability of clinical trial sites

Extent: E+W+S+N.I.

The facilities where the clinical trial is to be conducted shall be suitable for the conduct of the clinical trial in compliance with the requirements of this Regulation.

---
Source: https://www.legislation.gov.uk/eur/2014/536/article/50 (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-536/article-50
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.